Preimplantation Genetic Testing in Women of Advanced Maternal Age

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age35-40
SponsorGenomic Prediction Inc.

About this trial

The GETSET trial is a prospective randomized trial designed to evaluate the clinical outcomes of incorporating preimplantation genetic testing for aneuploidies (PGT-A) in elective single embryo transfer in women between 35 and 40 years of age.

Eligibility criteria

Qualifiers

Women undergoing IVF of between 35 and 40 years of age at IVF cycle start

Utilization of Intracytoplasmic Sperm Injection ICSI

Utilization of ejaculated or testicular sperm

Utilization of autologous or donor sperm

Disqualifiers

Patients with anovulatory Polycystic ovarian syndrome (PCOS)

Utilization of donor oocytes

Utilization of gestational carrier

Recurrent Pregnancy Loss (RPL) defined as ≥ 3 consecutive miscarriages

Trial design

Treatments tested in this trial

  • Preimplantation genetic testing for aneuploidy (PGT-A)

Treatment groups

240 Participants
are divided into 2 treatment groups

Sponsors and collaborators